JOHN DENNIS: Open Payments
NPI 1043218878 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 35 payments from 11 companies in 2025. Trend: 2023 $545 · 2024 $938 · 2025 $904
Food & beverage: $902Education: $2
| Company | Payments | Amount |
|---|---|---|
| Aurinia Pharma U.S., Inc. | 6 | $229 |
| Fresenius USA Marketing, Inc. | 6 | $143 |
| Travere Therapeutics, Inc. | 5 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Ardelyx, Inc. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Calliditas Therapeutics US Inc. | 2 | $42 |
| Amgen Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: LUPKYNIS, VELPHORO, JARDIANCE, Kerendia, IBSRELA, JYNARQUE, TARPEYO, TAVNEOS.
Industry payments across GA — which companies pay providers there.
